Tissue Repair Ltd Market Cap ($5.56 Million)
Market Cap & Net Worth: Tissue Repair Ltd (TRP)
Tissue Repair Ltd market cap. Tissue Repair Ltd (AU:TRP) has a market capitalization of $5.56 Million (AU$7.86 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28280 globally and #1446 in its home market, demonstrating a 51.16% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tissue Repair Ltd's stock price AU$0.13 by its total outstanding shares 60464843 (60.46 Million). Also see cash efficiency ratio of Tissue Repair Ltd for how efficiently the company converts equity into cash flow.
Tissue Repair Ltd Market Cap History (2021–2026)
Tissue Repair Ltd market cap history from 2021 to 2026. Data shows change from $23.32 Million to $5.56 Million (-28.64% CAGR). Check today's stock price for Tissue Repair Ltd for real-time trading data and today's change.
Tissue Repair Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tissue Repair Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Tissue Repair Ltd (TRP) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.26x
Tissue Repair Ltd's market cap is 6.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $23.32 Million | $152.64K | -$915.23K | 152.76x | N/A |
| 2022 | $9.84 Million | $171.92K | -$6.84 Million | 57.24x | N/A |
| 2023 | $9.41 Million | $3.08K | -$4.17 Million | 3059.88x | N/A |
| 2024 | $11.98 Million | $152.24K | -$4.14 Million | 78.69x | N/A |
| 2025 | $16.47 Million | $2.63 Million | -$4.24 Million | 6.26x | N/A |
Competitor Companies of TRP by Market Capitalization
Companies near Tissue Repair Ltd in the global market cap rankings as of November 8, 2026. Also see TRP asset base for a full breakdown of the balance sheet.
Key companies related to Tissue Repair Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Tissue Repair Ltd (2021–2026)
Market capitalization of Tissue Repair Ltd from 2021 to today. Between 2021 and today, Tissue Repair Ltd's market cap moved from $23.32 Million to $ 5.56 Million, with a yearly change of -28.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$5.56 Million | -66.23% |
| 2025 | AU$16.47 Million | +37.50% |
| 2024 | AU$11.98 Million | +27.27% |
| 2023 | AU$9.41 Million | -4.35% |
| 2022 | AU$9.84 Million | -57.80% |
| 2021 | AU$23.32 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Tissue Repair Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.56 Million USD |
| MoneyControl | $5.56 Million USD |
| MarketWatch | $5.56 Million USD |
| marketcap.company | $5.56 Million USD |
| Reuters | $5.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more